The detailed information for PTAB case with proceeding number IPR2021-01136 filed by Sarepta Therapeutics, Inc. against National Center of Neurology and Psychiatry et al. on Jun 21, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2021-01136
Filing Date
Jun 21, 2021
Petitioner
Sarepta Therapeutics, Inc.
Respondent
National Center of Neurology and Psychiatry et al.
Status
Terminated
Respondent Application Number
16364451
Respondent Tech Center
1600
Respondent Patent Number
10407461
Institution Decision Date
Jan 13, 2022
Termination Date
Jun 14, 2022

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

TERMINATION Dismissal After Institution of Trial 37 C.F.R. 42.72

Jun 14, 2022PAPERBOARD

Compelled Motion in Compliance with Court Order

May 25, 2022PAPERPETITIONER

Ex 3010 C.A. No. 21-1015 order

May 18, 2022EXHIBITBOARD

Ex 3009 e-mail to board

May 18, 2022EXHIBITBOARD

Order: Other

Apr 25, 2022PAPERBOARD

Ex. 3008

Apr 22, 2022EXHIBITBOARD

Order: ORDER Suspending Proceedings 37 C.F.R. § 42.5

Feb 24, 2022PAPERBOARD

Exhibit 3007

Feb 18, 2022EXHIBITBOARD

Exhibit 3005

Feb 18, 2022EXHIBITBOARD

Exhibit 3004

Feb 18, 2022EXHIBITBOARD

Exhibit 3002

Feb 18, 2022EXHIBITBOARD

Exhibit 3003

Feb 17, 2022EXHIBITBOARD

Petitioner's Opposition to Patent Owners' Motion for Additional Discovery

Feb 11, 2022PAPERPETITIONER

Petitioner's Updated Exhibit List as of February 11, 2022

Feb 11, 2022PAPERPETITIONER

FDA Orange Book

Feb 11, 2022EXHIBITPETITIONER

US 9,024,007

Feb 11, 2022EXHIBITPETITIONER

Sarepta 10-Q Excerpt

Feb 11, 2022EXHIBITPETITIONER

Petitioner's Objections to Patent Owners' Evidence Submitted with Patent Owners' Motion for Additional Discovery

Feb 9, 2022PAPERPETITIONER

Exhibit 3006

Feb 3, 2022EXHIBITBOARD

Patent Owner's Request for Additional Discovery

Feb 2, 2022PAPERPATENT OWNER

EXHIBIT 2053 Patent Owner RFP

Feb 2, 2022EXHIBITPATENT OWNER

EXHIBIT 2054 Del Complaint

Feb 2, 2022EXHIBITPATENT OWNER

EXHIBIT 2055 Patent Claim Chart 461 Patent

Feb 2, 2022EXHIBITPATENT OWNER

EXHIBIT 2056 Prescribing Information Vyondys 53

Feb 2, 2022EXHIBITPATENT OWNER

EXHIBIT 2057 Financial Results

Feb 2, 2022EXHIBITPATENT OWNER

EXHIBIT 2058 Phase I_II Study of SRP-4053 in DMD Patients

Feb 2, 2022EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Feb 2, 2022PAPERPATENT OWNER

Petitioner's Objections to Patent Owners' Evidence

Jan 24, 2022PAPERPETITIONER

Patent Owner's Objections to Petitioner's Evidence

Jan 24, 2022PAPERPATENT OWNER

DECISION Granting Institution of Inter Partes Review 35 U.S.C. 314

Jan 13, 2022PAPERBOARD

Scheduling Order

Jan 13, 2022PAPERBOARD

Order: Granting Patent Owners Unopposed Motion to Seal and Entering the Default Protective Order

Jan 7, 2022PAPERBOARD

Patent Owner's Sur-Reply to Petitioner's Reply to 136 Petition

Nov 12, 2021PAPERPATENT OWNER

Petitioner's Reply to Patent Owners' Preliminary Response

Nov 5, 2021PAPERPETITIONER

Petitioner's Updated Exhibit List

Nov 5, 2021PAPERPETITIONER

Memorandum Order No. 47

Nov 5, 2021EXHIBITPETITIONER

Memorandum Order No. 72

Nov 5, 2021EXHIBITPETITIONER

Order: Conduct of the Proceeding 37 C.F.R. § 42.5

Nov 1, 2021PAPERBOARD

Email: From: Raich, William To: Trials Cc: Bregman, Dion M subject: Sarepta Therapeutics, Inc. v. Nippon Shinyaku Co., Ltd. et al, IPR2021-01134 Date: Monday, October 25, 2021

Oct 29, 2021EXHIBITBOARD

PATENT OWNER NIPPON SHINYAKU CO., LTD.'S UPDATED MANDATORY NOTICES ADDING GUYLAINE HACHE

Oct 27, 2021PAPERPATENT OWNER

Motion to Seal pursuant to 37 CFR 42.55

Oct 21, 2021PAPERPATENT OWNER

EXHIBIT 2001 Monaco 1988

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2002 Beggs Article

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2003 Aartsma-Rus 2016

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2004 YokotaA Renaissance for Antisense Oligonucleotide

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2005 361 Pat FH 12-6-15 Original Claims

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2006 361 Pat FH Second Prelim Amendment

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2007 361 Pat FH 3-25-2016 Office Action

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2008 361 Pat FH 7-22-16 Amendment and Response to Office Action

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2009 361 Pat FH 10-27-16 Office Action

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2010 361 Pat FH 2-27-17 Amendment and Response to Office Action

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2011 361 Pat FH Notice of Allowance

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2012 361 Pat FH IDS

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2013 225 Pat FH excerpt

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2014 417 Pat FH excerpt

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2015 416 Pat FH excerpt

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2016 948 Pat FH excerpt

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2017 533 App FH 8-28-2017 response

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2018 918 Pat FH excerpt

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2019 533 App FH 12-14-2018 response

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2020 480 App FH 2-18-2016 response

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2021 Corey Nucleic Acid Research 2018

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2022 641 App FH 9-29-2015 Response

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2023 US20070265215A1

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2024 641 App FH 10-16-2015 Office Action

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2025 641 App FH 3-16-16 Response

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2026 Agreement FILED UNDER SEAL

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2033 461 Pat FH Original Claims

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2034 461 Pat FH First Preliminary Amendment

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2035 461 Pat FH Second Preliminary Amendment

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2036 461 Pat FH Interview Summary

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2037 461 Pat FH Terminal Disclaimers

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2038 461 Pat FH Notice of Allowance

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2039 461 Pat FH After-Allowance Amendment

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2040 461 Pat FH Response to After-Allowance Amendment

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2049 600 Pat FH 9-18-2019 Response

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2050 US 11,000,600

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2051 US20130211062

Oct 21, 2021EXHIBITPATENT OWNER

EXHIBIT 2052 533 App FH - Declaration of Fred Schnell

Oct 21, 2021EXHIBITPATENT OWNER

Patent Owners Preliminary Response 461 Patent -136 Petition SEALED

Oct 21, 2021PAPERPATENT OWNER

Patent Owners Preliminary Response 461 Patent -136 Petition REDACTED

Oct 21, 2021PAPERPATENT OWNER

Patent Owner National Center of Neurology and Psychiatry's Mandatory Notice Pursuant to 37 C.F.R. Section 42.8(a)(2)

Aug 4, 2021PAPERPATENT OWNER

Patent Owner National Center of Neurology and Psychiatry's Power of Attorney

Aug 4, 2021PAPERPATENT OWNER

Petitioner's Updated Mandatory Notices

Jul 22, 2021PAPERPETITIONER

Patent Owner Nippon Shinyaku's Mandatory Notice Pursuant to 37 C.F.R. Section 42.8(a)(2)

Jul 21, 2021PAPERPATENT OWNER

Patent Owner Nippon Shinyaku's Power of Attorney

Jul 21, 2021PAPERPATENT OWNER

EXPUNGED

Jul 21, 2021PAPERBOARD

Notice of Accord Filing Date

Jul 21, 2021PAPERBOARD

U.S. Patent No. 10,407,461

Jun 21, 2021EXHIBITPETITIONER

PCT WO 2012/029986

Jun 21, 2021EXHIBITPETITIONER

NS JP App. No. 2010-196032

Jun 21, 2021EXHIBITPETITIONER

English Translation for JP Provisional

Jun 21, 2021EXHIBITPETITIONER

English Translation of PCT WO 2012/029986

Jun 21, 2021EXHIBITPETITIONER

Certificate JP 2010-196032

Jun 21, 2021EXHIBITPETITIONER

PCT certificate JP 2011-070318

Jun 21, 2021EXHIBITPETITIONER

'361 Patent FH excerpts

Jun 21, 2021EXHIBITPETITIONER

'461 Patent FH excerpts

Jun 21, 2021EXHIBITPETITIONER

Popplewell 2010

Jun 21, 2021EXHIBITPETITIONER

Sazani 2010

Jun 21, 2021EXHIBITPETITIONER

US 2010/0168212 (Popplewell)

Jun 21, 2021EXHIBITPETITIONER

US 2010/0130591 (Sazani US)

Jun 21, 2021EXHIBITPETITIONER

US 2013/0109091 (Baker)

Jun 21, 2021EXHIBITPETITIONER

US 2012/0190728 (Bennett)

Jun 21, 2021EXHIBITPETITIONER

Bushby 2010

Jun 21, 2021EXHIBITPETITIONER

Kinali 2009

Jun 21, 2021EXHIBITPETITIONER

Hoffman 2007

Jun 21, 2021EXHIBITPETITIONER

Wilton 2008

Jun 21, 2021EXHIBITPETITIONER

Arechavala-Gomeza 2007

Jun 21, 2021EXHIBITPETITIONER

Ginjaar 2000

Jun 21, 2021EXHIBITPETITIONER

Wilton 2005

Jun 21, 2021EXHIBITPETITIONER

Wilton 2007

Jun 21, 2021EXHIBITPETITIONER

Muntoni 2010

Jun 21, 2021EXHIBITPETITIONER

van Deutekom 2007

Jun 21, 2021EXHIBITPETITIONER

Goemans 2011

Jun 21, 2021EXHIBITPETITIONER

Cirak 2011

Jun 21, 2021EXHIBITPETITIONER

Nakamura 2009

Jun 21, 2021EXHIBITPETITIONER

Yokota 2009

Jun 21, 2021EXHIBITPETITIONER

Aartsma-Rus 2009(b)

Jun 21, 2021EXHIBITPETITIONER

Aartsma-Rus 2009(c)

Jun 21, 2021EXHIBITPETITIONER

Chan 2006

Jun 21, 2021EXHIBITPETITIONER

Summerton 1997(a)

Jun 21, 2021EXHIBITPETITIONER

Adams 2007

Jun 21, 2021EXHIBITPETITIONER

US 2003/0166588

Jun 21, 2021EXHIBITPETITIONER

Aartsma-Rus 2005

Jun 21, 2021EXHIBITPETITIONER

WO 2004/083432 (Leiden)

Jun 21, 2021EXHIBITPETITIONER

WO 2006/000057 (Wilton 1 PCT)

Jun 21, 2021EXHIBITPETITIONER

US 2007/0082861 (Matsuo 5)

Jun 21, 2021EXHIBITPETITIONER

Popplewell 2009

Jun 21, 2021EXHIBITPETITIONER

Moulton 2009

Jun 21, 2021EXHIBITPETITIONER

WO 2011/057350 (Wilton 2 PCT)

Jun 21, 2021EXHIBITPETITIONER

Summerton 1999

Jun 21, 2021EXHIBITPETITIONER

Muntoni 2008

Jun 21, 2021EXHIBITPETITIONER

Aartsma-Rus 2007

Jun 21, 2021EXHIBITPETITIONER

Trollet 2009

Jun 21, 2021EXHIBITPETITIONER

Prosensa and GlaxoSmithKline

Jun 21, 2021EXHIBITPETITIONER

Vickers 2000

Jun 21, 2021EXHIBITPETITIONER

OA 14-776,533 dated Nov 16 2017

Jun 21, 2021EXHIBITPETITIONER

Abandonment 14-776,533 dated Mar 20, Apr 5 2019

Jun 21, 2021EXHIBITPETITIONER

Interference 106,007 Paper 476 May 12 2016

Jun 21, 2021EXHIBITPETITIONER

McClorey 2006

Jun 21, 2021EXHIBITPETITIONER

US 61-591,354 (PRO6)

Jun 21, 2021EXHIBITPETITIONER

Mann 2002

Jun 21, 2021EXHIBITPETITIONER

Albert 4th Ed (Ch. 4 + Ch. 6)

Jun 21, 2021EXHIBITPETITIONER

Douglas and Wood 2013

Jun 21, 2021EXHIBITPETITIONER

Dominski & Kole (1993)

Jun 21, 2021EXHIBITPETITIONER

Dominski & Kole (1994)

Jun 21, 2021EXHIBITPETITIONER

Sierakowska et al. (1996)

Jun 21, 2021EXHIBITPETITIONER

Aartsma-Rus 2002

Jun 21, 2021EXHIBITPETITIONER

Bremmer-Bout et al. (2004)

Jun 21, 2021EXHIBITPETITIONER

US 2009/0131624 A1

Jun 21, 2021EXHIBITPETITIONER

US 2009/0088562 A1

Jun 21, 2021EXHIBITPETITIONER

U.S. Patent No. 5,185,444

Jun 21, 2021EXHIBITPETITIONER

Experimental Report filed in EP 3018211

Jun 21, 2021EXHIBITPETITIONER

Declaration of Dr. Ueda filed in EP 3018211

Jun 21, 2021EXHIBITPETITIONER

Preliminary Opinion from OD in EP 3018211

Jun 21, 2021EXHIBITPETITIONER

Hayes Greenhill Declaration

Jun 21, 2021EXHIBITPETITIONER

Corey Declaration

Jun 21, 2021EXHIBITPETITIONER

Petition for Inter Partes Review

Jun 21, 2021PAPERPETITIONER

Petitioner Sarepta Therapeutics, Inc.'s Power of Attorney and Designation of Lead and Backup Counsel

Jun 21, 2021PAPERPETITIONER